- Glenmark Life Science
Glenmark Life Science Share Price
NSE: ALIVUS | BSE: 543322
₹1,100.10
-₹15.50 (-1.39%) Last updated on 12 May, 2025 | 15:46 ISTMarket cap  ₹13,681 Crs | Open ₹1,129.70 | Prev. Close ₹1,115.60 |
Circuit range ₹1,338.70 - ₹892.50 | Day range ₹1,089.90 - ₹1,135.00 | Year range ₹755.95 - ₹1,335.10 |
Volume 1,10,638 | Avg. traded ₹1,107.30 | Revenue (12m) ₹2,274 Crs |
About Glenmark Life Science
Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, is an India-based developer and manufacturer of non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas. The Company is providing contract development and manufacturing (CDMO) services to a range of multinational and specialty pharmaceutical companies. Its primary therapy areas include cardiovascular (CVS) disease, central nervous system (CNS) disorders, diabetes, oncology, pain management (anti-migraine, analgesic) and anti-infectives (antibiotic). It also develops APIs in the therapeutic areas such as antifungal, anti-histaminic, anti-acne, anti-emetic, ophthalmologic agent, urinary and anti-spasmodic. It has a diversified portfolio of around 151 molecules & supplies its products to customers in India, Europe, North America, Latin America, Japan and the rest of the world. Its four manufacturing facilities are located in Ankleshwar, Dahej, Mohol and Kurkumbh.
Glenmark Life Science Share Price Chart
Please wait...
Glenmark Life Science Key Indicators
P/E ratio 31.04 | P/B ratio 4.81 | ROE 21.15% |
ROCE 28.31% | Dividend yield 2.14% | Debt/Equity ratio |
EPS 38.43 |
Featured in
Investment Checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst Ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 3 experts in the last 7 days
Glenmark Life Science Financial Ratios
Operating profit margin29.97% | Net profit margin20.56% |
ROE21.15% | ROA13.96% |
ROCE28.31% |
Quick ratio2.85 | Current ratio4.37 |
Interest coverage409.34 | Asset turnover0.68 |
Debt to Equity0 |
P/E ratio31.04 | P/B ratio4.81 |
EV / EBITDA13.4 | |
Dividend yield2.14% |
Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
| No data found | |||
Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
| No data found | |||
Balance Sheet
All values are in ₹ Crores (Cr)
No data available at the moment
Glenmark Life Science Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
12-May-25 | ₹1,129.70 | ₹1,100.10 | -1.39% |
09-May-25 | ₹1,075.30 | ₹1,115.60 | |
08-May-25 | ₹1,115.50 | ₹1,106.10 | -1.14% |
07-May-25 | ₹1,088.80 | ₹1,118.90 | |
06-May-25 | ₹1,080.00 | ₹1,111.00 | |
05-May-25 | ₹1,098.00 | ₹1,087.90 | -0.06% |
02-May-25 | ₹1,097.00 | ₹1,088.60 | -1.39% |
30-Apr-25 | ₹1,079.10 | ₹1,104.00 |
Events
Corporate Actions
Dividend • ₹22.5/share
Ex date 17 Oct 2023
More
Stocks Similar to Glenmark Life Science
Stock Name | Price | Change % |
|---|---|---|
| Aarti Drugs | ₹428.40 | +₹9.75 (2.33%) |
| AstraZeneca Pharma Ind | ₹8,119.50 | +₹149.00 (1.87%) |
| Caplin Point Lab | ₹1,944.40 | +₹83.50 (4.49%) |
| FDC Limited | ₹435.15 | +₹5.60 (1.30%) |
| Granules India | ₹460.15 | +₹19.25 (4.37%) |
| Hikal | ₹398.65 | +₹11.65 (3.01%) |
| Jubilant Ingrevia | ₹717.60 | +₹24.65 (3.56%) |
| Jubilant Pharmova | ₹879.80 | +₹11.95 (1.38%) |
| Procter & Gamble Health | ₹5,092.00 | +₹52.50 (1.04%) |
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| HDFC Bank | ₹1,957.20 | +₹67.50 (3.57%) |
| Indian Railway Finance Corp | ₹125.53 | +₹9.11 (7.83%) |
| Indian Railway Tourism Corp | ₹763.45 | +₹40.90 (5.66%) |
| ITC | ₹435.50 | +₹11.95 (2.82%) |
| JIO FIN SERVICES LTD | ₹262.90 | +₹14.55 (5.86%) |
| Reliance Industries | ₹1,436.50 | +₹59.30 (4.31%) |
| Tata Motors | ₹720.80 | +₹12.30 (1.74%) |
| Tata Power | ₹391.40 | +₹20.40 (5.50%) |
| Tata Steel | ₹151.63 | +₹8.85 (6.20%) |
| Wipro | ₹257.28 | +₹15.27 (6.31%) |
Glenmark Life Science News
Livemint
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares
Livemint
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares!
DSIJ
Alivus Life Enters Into Share Purchase Agreement with Torrent Urja 19
Moneycontrol
Alivus Life Standalone December 2024 Net Sales at Rs 641.84 crore
FAQs on Glenmark Life Science
What is the share price of Glenmark Life Science today?
Glenmark Life Science share price is ₹ 1,100.10 as on May 13, 2025 | 05:28 IST.
What are the high & low share price of Glenmark Life Science today?
Glenmark Life Science share price hit a high of ₹ 1,135.00 and low of ₹ 1,089.90 as on May 13, 2025 | 05:28 IST.
What are the the 52-week high and low share prices of Glenmark Life Science share on the NSE?
52-week high share Price of Glenmark Life Science is ₹ 1,335.10 and Low Price is ₹ 755.95 as on May 13, 2025 | 05:28 IST.
What is the stock symbol of Glenmark Life Science?
The stock symbol of Glenmark Life Science is ALIVUS.
Can I buy Glenmark Life Science shares on Holidays?
No, shares of Glenmark Life Science or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Glenmark Life Science shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.